Healthcare analytics, AI solutions for biological big data, providing an AI platform for the biotech, life sciences, medical and pharmaceutical industries, as well as for related technological approaches, i.e., curation and text analysis with machine learning and other activities related to AI applications to these industries.
Day One at #JPM16: Breakout sessions of 23andMe, Myriad Genetics, Genomic Health, and Alere, Volume 2 (Volume Two: Latest in Genomics Methodologies for Therapeutics: Gene Editing, NGS and BioInformatics, Simulations and the Genome Ontology), Part 1: Next Generation Sequencing (NGS)
Day One at #JPM16: Breakout sessions of 23andMe, Myriad Genetics, Genomic Health, and Alere
Reporter: Aviva Lev-Ari, PhD, RN
JP Morgan Healthcare Conference, Day One: 23andMe; Myriad Genetics; Genomic Health; Alere
SAN FRANCISCO (GenomeWeb) – The 34th Annual JP Morgan Healthcare Conference began here Monday with several life science research tools and diagnostic firms making presentations to investors and other attendees.
The following are capsules from the presentations and breakout sessions of 23andMe, Myriad Genetics, Genomic Health, and Alere. Coverage of Illumina’s presentation is available here.
Leave a Reply